We have reported previously the detection of two stable immediate-early (IE) transcripts that accumulate in cycloheximide-treated cells infected with herpesvirus saimiri (HVS). These are the 1.6-kb mRNA from the 52-kDa gene (which is homologous to the BSLF2-BMLF1 gene of Epstein-Barr virus) and the 1.3-kb mRNA from the HindM-G fragment of virus DNA. In order to study the roles of the HVS IE gene products in the progression of a lytic infection, the promoter region of the delayed-early 110-kDa gene of HVS was sequenced, the transcription initiation site was mapped by RNase protection, and the promoter sequences were cloned upstream of the chloramphenicol acetyltransferase (CAT) gene. Sequences between -447 and +37 (relative to the 110-kDa transcription initiation site) were sufficient for response to HVS superinfection of transfected cells, but the 110-kDa promoter was activated only poorly by the 52-kDa and HindIll-G IE (IE-G) proteins in cotransfection experiments. However, a distinct region of the genome, EcoRI-D (15 kbp), was able to activate 110-kDa-CAT expression relatively efficiently in similar experiments. A 4.7-kbp PstI fragment encoding this function was isolated and sequenced, and further subcloning identified the gene encoding the EcoRI-D trans activator. This gene, which we now designate HVS.R, is homologous to the BRLFl-encoded transcriptional effector of Epstein-Barr virus.
Herpesvirus saimiri (HVS) establishes asymptomatic latent infections in T lymphocytes of its natural host, the squirrel monkey (Saimiri sciureus), but causes fatal lymphomas and lymphoproliferative diseases in other species of New World primates. HVS has been classified as a gammaherpesvirus on the basis of its biological properties, and recent sequencing studies have shown it to be closely related to the human gammaherpesvirus Epstein-Barr virus (EBV) (1, 7, 17, 18, 23, 31) . HVS productively infects epithelial and fibroblastic cells in culture, and this property has allowed the identification of more than 30 virus-specified proteins and the analysis of HVS gene regulation. As in other herpesviruses, the pattern of gene expression occurs in the three main temporal phases: immediate-early (IE), delayed-early (DE), and late. Two stable HVS IE transcripts that map to the 52-kDa and HindIII-G genes have been identified (31, 32) . These genes are transcribed in the absence of de novo protein synthesis and thus require only cellular proteins for their expression. DE gene expression requires the prior synthesis of at least one of the IE gene products, whereas late gene expression occurs maximally after the onset of virus DNA replication (6, 32, 35) . Thus, the viral IE genes encode the trans-acting proteins required for activation of DE gene expression and onset of the lytic cycle.
In EBV, three trans activators have been identified. These are the products of the BZLF1, BSLF2-BMLF1, and BRLF1 genes (4, 9, 10, 20, 28, 33, 42, 45) . The HVS IE 52-kDa gene is homologous to the BMLF1 reading frame, and previous studies have shown that the 52-kDa protein is able to activate chloramphenicol acetyltransferase (CAT) expression from heterologous promoter-CAT constructs in transient transfection assays (31, 32) . However, the role of the IE 52-kDa protein in the regulation of a productive HVS infection has not been determined. Similarly, no function for the product of the HindIII-G IE gene (IE-G) in the regulation of HVS gene expression has been demonstrated. In this report, we describe experiments designed to investigate the regulation of an HVS DE promoter, that of the 110-kDa gene (5, 6, 17, 35) , by the HVS IE gene products. Our results show that although the 110-kDa promoter is weakly induced by the 52-kDa and IE-G proteins, the promoter is activated very efficiently by a gene product encoded by the EcoRI-D fragment of HVS L-DNA. The EcoRI-D trans activator is homologous to the EBV BRLF1 gene product. Therefore, of the three IE/trans-activating genes of EBV and HVS, two are structurally and functionally conserved. These results further demonstrate the similarities between these two gammaherpesviruses.
MATERIALS AND METHODS
DNA sequencing. The 110-kDa N-terminal coding and promoter regions were isolated as a 1.9-kbp KpnI-PstI fragment from pKpnI-F (25) . This fragment was sonicated, end repaired, and cloned into the SmaI site of M13mpl8 as previously described (3) . Clones were sequenced by the dideoxy-chain terminator procedure of Sanger et al. (41) to produce overlapping stretches of sequence which were assembled as previously described (7) . The 4.7-kbp PstI fragment from EcoRI-D (dD4.7) was sequenced by using the same procedures. RNA 10  20  30  40  50  60  70   80   90  100  110  120   _TAG TTTCAAGG.AATCTAATACGTGTAACCATGGAGTATGGTCTCCAGCTATTCTGAGAAGTTTTTAAGQCTCTGAAAT   130  140  150  160  170  180  190  200  210  220  230  240   CAAATGAAGATAATTCTACACCTT AGAGTTcAcAA-MAAcAcTCCcACT AAAAAATATCGGGTTCATAAAATCCCTA   250  260  270  280  290  300  310  320  330   340  350  360   CTCGGGAAAACCTATAAACTTCCTCGGGGAGTTCTAGTAATTATTCTTACcAAGTTTATTcATAATATGGGGTAAACCAATTCTTC   370  380  390  400  410  420  430  440  450  460  470  480   GGCAGTAACTACC   CATAACAAGGACTTACATTCCCGACACATCATACATA   490  500  510  520  530  540  550  560  570  580  590   600   610  620  630  640  650  660  670  680  690  700  710  720   R   TCTTC TTGTNANU:TASC&-IGTGTTTTGCCTTCAAGTGQAATAvAATTCGTAA AATTAAAAAATTGTTTTTATATGTGATACAAACAAGCACCCATT   730  740  750  760  770  780  790  800  810  820  830  840   API   CTGTCAATGTGGTTTGCTTGAAGITSCTAGTTATATATCTTTGAA   850  860  870  880  890  900  910  920  930  940  950  960   TATA   I   N   GTTCAACAAGTTAAIAAGCCASTTATTAAACCTSAsCAGAATGTAACTGTAGTG   A CC  CACATCTAACAATG  970  980  990  1000  1010  1020  1030  1040  1050  1060 1070 CCAAAGAAGGtTCTTTTAAAGAAGCTTCCTTCTA   1090  1100  1110  1120  1130  1140  1150   1160  1170  1180 1190 1200 T T L   1210  1220  1230  1240  1250  1260  1270  1280  1290  1300  1310 FIG. 1 . Nucleotide sequence of the N-terminal coding and upstream region of the 110-kDa gene. The translation of the 5' coding sequence is shown (nucleotides 1078 to 1320) in single-letter code, beginning at the predicted initiation methionine. Also indicated on the nucleotide sequence are the transcription initiation site (arrow, position 1039), putative AP1 binding site, and TATA box. The position of a PstI cleavage site (P), introduced by mutagenesis and used to clone promoter sequences into CAT vectors (see Materials and Methods), and a RsaI site (R), utilized for the generation of an SP6 probe for RNase protection mapping, are indicated by closed and open arrowheads, respectively. newborn calf serum were infected with HVS strain 11(0) (14) at 50 PFU per cell or mock infected in the presence or absence of cycloheximide (50 ,ug/ml) as previously described (37) . Cells were harvested at 20 h postinfection, and total RNA was prepared (11) and treated with DNase I (RQ1 DNase; Promega). SP6 RNase protection. An M13 clone (mllOK) containing a sonicated DNA fragment (nucleotides 1 to 1208 of the 110-kDa sequence [ Fig. 1 ]) was digested with BamHI and EcoRI (flanking sites in mpl8 polylinker) to remove the insert, which was then cloned into the SP6 transcription vector pSP72 (Promega) to create pSP11OK. [a-32P]UTPlabeled antisense transcripts were made from the SP6 promoter, hybridized to 1 ,ug of total RNA, RNase digested, and analyzed on 6% acrylamide-8 M urea gels (41) essentially as described by Melton et al. (30) , except that hybridizations were done in 60% formamide at 42°C because of the AT-rich nature of the HVS genome (22) .
Plasmids. The CAT expression vector pUCATPV (gift from P. Vize) was constructed by cloning a 1.63-kb bluntended HindIII-BamHI fragment from pSVO-cat (19) (25) . Subfragments of EcoRI-D were generated by restriction endonuclease digestion and cloned into pUC19 to generate pdD4.7, pdD3.0, pdD5.4, pdD9.6, and pdD1.9 (see text for details).
Transfection assays. Cells were transfected with plasmid DNA essentially as described previously (19) . Calcium phosphate precipitates were applied for 10 h prior to changing the medium, and cells were harvested either 24 to 36 h (EcoRI-D and EcoRI-D subclone cotransfections) or 60 to 72 h (52-kDa and HindIII-G cotransfections) after changing the medium. Cells were assayed for CAT activity as described by Gorman et al. (19) , and percentages of acetylation were calculated by the scintillation counting of appropriate regions of the chromotography plate.
Nucleotide sequence accession number. The 110-kDa and dD4.7 sequences reported in this article will appear in the EMBL, GenBank, and DDBJ nucleotide sequence data bases under the accession numbers M60849 and M60850, respectively.
RESULTS
Mapping the l1O-kDa promoter. The location of the 110-kDa transcription start site was determined by SP6 RNase protection (30) . The plasmid pSP110K (see Materials and Methods) was digested with RsaI ( Fig. 1) , and a 443-nucleotide transcript was generated from the SP6 promoter. Following hybridization with HVS-infected and uninfected Vero cell RNA samples and RNase digestion, a 170-nucleotide protected fragment was generated (Fig. 2) . This maps the 110-kDa gene cap site to nucleotide 1039, 39 bp 5' to the ATG initiation codon. This was confirmed by additional protection experiments with different probes (data not shown).
Analysis of the promoter sequence reveals a consensus AP1 site (TGAGTCA) (26) at -98 and a TATA sequence at -34 from the cap site ( Fig. 1 ). AP1 sites are also found in the promoter regions of the homologous EBV and varicellazoster virus (VZV) genes and occur in analogous positions relative to putative TATA box elements (2, 13) . A conserved AP1 site has also been found in the HVS IE 52-kDa promoter (31) , and their functional relevance in the regulation of EBV gene expression (15, 44) suggests that they may play an analogous role in HVS.
Response of the 11O-kDa promoter to HVS superinfection. Two fragments of the 110-kDa promoter containing sequences -447 to +37 and -1038 to +33 were cloned into the CAT vector pUCATPV (as described in Materials and Methods) to generate p11OCAT.A and p11OCAT.B, respectively. The -447 to +37 fragment was also cloned in reverse orientation relative to the direction of transcription of the CAT gene to generate p11OCAT.AR (Fig. 2c) Fig. 1 .
Response of the 11O-kDa promoter to HVS IE gene products. Two HVS IE genes have been previously identified; these are the 52-kDa and the HindIII-G genes (31, 32, 38 ).
The 52-kDa gene, when used in cotransfection assays, is able to activate expression from heterologous promoter-CAT constructs (31, 31a and right PstI sites (Fig. 5A, pdD3 .0) abolished activity. Therefore, sequences within the 1.7-kbp XbaI-PstI fragment were important for trans activation.
Identification of the trans-regulatory gene within EcoRI-D. As the 4.7-kbp PstI fragment was sufficient for trans activation of the 110-kDa promoter, we sequenced this region (see Materials and Methods). The nucleotide sequence determined is shown in Fig. 6 and contains three ORFs (RF1, RF2, and RF3 in Fig. 5A ). As predicted from their positions and orientations within the HVS genome relative to EBV, RF1 and RF3 are homologous to the EBV BRLF1 and BRRF1 genes, respectively. Thus, these genes and their relative locations are conserved between HVS and EBV. Although the BRLF1 gene product has been identified as a transcriptional activator, the function of the BRRF1-encoded protein is unknown. Alignments between the proteins encoded by these ORFs and their homologs in HVS are shown in Fig. 7 . It is important to note that the first methionine codon in RF1 occurs far into the ORF (amino acid position 131), although the similarity between the RF1-and BRLFl-encoded proteins begins near their N termini. We would therefore predict splicing of the primary transcript from the RF1 gene, allowing the utilization of an initiator methionine codon from sequences upstream of this ORF, as is the case for the IE 52-kDa mRNA (9a, 31). The translation product of RF2, which is in the predicted position and orientation for the BZLF1 homolog, shows little similarity to the product of this ORF. However, the transcript from the BZLF1 gene is spliced, and this alters the predicted amino acid sequence in the C-terminal region of the protein (4). This contains the basic and coiled-coil domain involved in DNA binding and protein-protein dimerization, features which are characteristic of the bZIP family of transcription factors (8, 27, 36) . It is possible that the mRNA from the RF2 gene is also spliced, which may reveal sequence similarities between the RF2 and BZLF1 proteins in their C-terminal domains.
As described above, the deletion of sequences between the XbaI site and the right PstI site in pdD4.7 to give pdD3.0 (Fig. 5A ) abolished trans activation of the 110-kDa promoter. Also, using the BamHI-EcoRI subclones pdD9.6 and pdD5.4 either alone or in combination in cotransfections with pKS11OCAT did not result in increased CAT activity. Thus, the XbaI and BamHI sites occur in regions of the 4.7-kbp PstI fragment important for trans activation, regions which are encompassed by RF1. We isolated and cloned RF1 and flanking sequences into pUC19 by utilizing the HindIII restriction sites present in the 4.7-kbp PstI fragment (lower part of Fig. 5A ). The resulting plasmid, pdD1.9, was used in cotransfections with pKS11OCAT and was found to trans activate 110-kDa-CAT expression with high efficiency (32-fold) (Fig. 5B) . Thus, RF1, the homolog of the BRLF1 gene of EBV, encodes the trans-acting function present in EcoRI-D. Because of the structural and functional conservation between the EBV R trans activator and the RF1 gene product, we now designate the HVS gene HVS.R.
DISCUSSION
In this report, we have investigated the roles of the IE 52-kDa and IE-G proteins in the regulation of HVS gene expression. For these studies, we chose to use the 110-kDa DE gene which specifies the HVS major DNA binding protein, the homolog of the ICP8, BALF2, and RF29 genes of HSV, EBV, and VZV, respectively. The promoter and N-terminal coding regions of the 110-kDa gene were sequenced and the transcriptional initiation site was determined, data which were then used to clone the 110-kDa promoter upstream of the CAT coding sequences. Promoter sequences from -447 to +37 (present in p11OCAT.A) were found to be sufficient for activation of CAT expression by HVS superinfection of transfected cells and to be functional in inverse orientation relative to the CAT gene, suggesting the presence of an enhancer within this fragment. It is intriguing that the HVS 110-kDa promoter contains a sequence corresponding to a binding site for the AP1 transcription factor, as AP1 sites are also found in the promoter regions of the homologous EBV and VZV genes and occur in analogous positions relative to putative TATA box elements (2, 13). Sequence elements identical or closely related to AP1 sites have been shown to be important in trans activation of target promoters by the BZLF1-encoded protein, these motifs forming functional binding sites for this trans activator (8, 15, 16, 21, 27, 36) .
Although the 110-kDa promoter responded well to HVS superinfection, it was activated only weakly when cotransfected with the two HVS IE genes, IE 52-kDa and IE-G, either alone or in combination. Unlike pKSVHG (containing the IE-G ORF under the control of the SV40 early promoter), the plasmid pHindIII-G did not effect significant activation of CAT activity in these cotransfection experiments, the most likely explanation being the lack of promoter sequences upstream of +22 relative to the IE-G transcriptional VOL. 65, 1991 2462 NICHOLAS ET AL. initiation site (9a) and consequent poor expression of the IE-G mRNA. However, this plasmid, together with p52K and the SV40 early promoter expression plasmids pKSV52 and pKSVHG, was able to support activation (approximately 6.5-fold) of the HSV IE 175K promoter, demonstrating that IE-G protein was being expressed from pHindIII-G.
The low levels of 110-kDa trans activation by the 52-kDa and HindIII-G gene products, relative to the levels of activation seen using these genes in cotransfection with heterologous promoter-CAT targets, led us to investigate the possibility that additional viral factors are involved in activation of the DE 110-kDa promoter. As mentioned previously, the arrangement of homologous genes between HVS and EBV is conserved (1, 17) . In addition to the EBV 52-kDa homolog, EB2 (BSLF2-BMLF1 encoded) (31), EBV encodes two other trans activators, Z (BZLF1 encoded) and R (BRLF1 encoded). These genes appear to be essential for the reactivation of latent EBV genomes. The BZLF1 gene 43 and 23% for RF1 and BRLF1 and 43 and 22% for RF2 and BRRF1. In the alignments, similar residues are indicated by a single dot or a pair of dots (joining well-conserved amino acids) and identical residues are indicated by vertical lines. product has been defined as the initial trigger for the lytic cycle (10, 39, 40, 42) , but its function is dependent on the presence of the BRLF1-encoded protein (9, 12, 24 (Fig. 5A) upstream of HVS.R (RF1) is homologous to the BRRF1 reading frame of EBV (2) , but the function of the encoded protein is unknown. Significant amino acid sequence similarities between the product of the downstream ORF, RF2, and its counterpart in EBV, BZLF1, were not detected, but the BZLF1 mRNA is known to be spliced, changing and extending the C-terminal portion of the encoded protein (4).
We do not yet have data on the structure of the RF2 mRNA.
It seems clear, however, that whereas the BRLF1 protein is encoded by a bicistonic mRNA containing BRLF1 and BZLF1 coding sequences (4, 29) , the HVS.R transcription unit appears to span only the HVS.R ORF and to be contained within the 1.9-kbp HindIII fragment of EcoRI-D (Fig. 5A) 
